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ABSTRACT
Objective: The objective of this study was to extend the Consequences of
Screening (COS) Questionnaire for use in a lung cancer screening by testing
for comprehension, content coverage, dimensionality, and reliability.
Methods: In interviews, the suitability, content coverage, and relevance of
the COS were tested on participants in a lung cancer screening program.
The results were thematically analyzed to identify the key consequences of
abnormal and false-positive screening results. Item Response Theory and
Classical Test Theory were used to analyze data. Dimensionality, objec-
tivity, and reliability were established by item analysis, examining the ﬁt
between item responses and Rasch models.
Results: Eight themes speciﬁcally relevant for participants in lung cancer
screening results were identiﬁed: “self-blame,” “focus on symptoms,”
“stigmatization,” “introvert,” “harm of smoking,” “impulsivity,”
“empathy,” and “regretful of still smoking.” Altogether, 26 new items for
part I and 16 new items for part II were generated.These themes were
conﬁrmed to ﬁt a partial-credit Rasch model measuring different con-
structs including several of the new items.
Conclusion: In conclusion, the reliability and the dimensionality of a
condition-speciﬁc measure with high content validity for persons having
abnormal or false-positive lung cancer screening results have been demon-
strated. This new questionnaire called Consequences of Screening in Lung
Cancer (COS-LC) covers in two parts the psychosocial experience in lung
cancer screening. Part I: “anxiety,” “behavior,” “dejection,” “sleep,” “self-
blame,” “focus on airway symptoms,” “stigmatization,” “introvert,” and
“harm of smoking.” Part II: “calm/relax,” “social network,” “existential
values,” “impulsivity,” “empathy,” and “regretful of still smoking.”
Keywords: lung cancer, psychometrics, public health, questionnaire devel-
opment, secondary prevention.
Introduction
Participation in cancer screening programs has an impact on
people’s lives regardless of the results of the screening. For
example, women have reported negative emotional consequences
as a result of receiving an invitation to breast cancer screening
[1–4]. By deﬁnition, screening tests are imperfect: screening can be
unresponsive to some cancers (false negatives or the so-called false
assurance) and, conversely, not infrequently raises the suspicion of
cancer among healthy persons (false positives or the so-called false
alarms). The impact of screening on people’s lives is more severe
for those receiving abnormal (including false positive) screening
results than for those receiving normal results [5–8].
Psychosocial consequences have been widely explored in
many different aspects of breast cancer and cervical cancer
screening [5], but little is known about the long-term psychoso-
cial consequences of cancer screening [9]. In breast cancer screen-
ing, the results from different studies on the long-term
psychosocial consequences of false-positive results are inconsis-
tent [6,10]. This is most likely caused by the inadequacy of the
instruments used to measure the psychosocial aspects [10,11].
In general, generic measures have been used in most surveys to
investigate potentially harmful psychosocial side effects of cancer
screening programs [5,6]. Nevertheless, these generic measures
lack content validity in terms of cancer screening [10,11]. Further-
more, various studies have shown that the psychometric proper-
ties of generic instruments are inconsistent across different
populations [12–14]. The use of generic measures becomes even
more problematic if a group of persons that fare least well are also
those who ﬁnd the generic instruments of least relevance [15]. It
has been shown that speciﬁc instruments are more sensitive than
generic instruments [16]. Therefore, when measuring psychoso-
cial consequences of screening, questionnaires with high content
validity and adequate psychometric properties are needed [17].
Nonrandomized trials on lung cancer screening using low-
dose spiral computed tomography (CT) scanning as the screening
test have given indications of substantial harm and no beneﬁts. In
a statistical prediction model, screening with spiral CT scans
resulted in an overdiagnosis of lung cancer: for every patient with
a diagnosis of lung cancer in the screening program, more than
two persons were captured with inconsequential lung cancers
[18]. Screening with spiral CT scans has also revealed a high
number of lung lesions among healthy persons, resulting in many
false-positive screening results [19–21]. None of these nonran-
domized trials have established sufﬁcient evidence for any beneﬁts
of screening for lung cancer with spiral CT scanning [22]. There-
fore, ﬁve randomized control trials have been launched on lung
cancer screening, using low-dose spiral CT scanning as the screen-
ing test [23–27].
Three studies have investigated potentially harmful psycho-
social aspects of lung cancer screening. A survey from the Pitts-
burgh Lung Screening Study concludes that persons with
abnormal screening results exhibit negative psychological effects
as a result of being screened—increased anxiety, increased per-
ceived risk of cancer, and fear of cancer after screening [28]. A
study from the Belgian-Dutch randomized controlled lung cancer
screening trial concludes that there are no negative Health
Related Quality of Life (HRQoL) effects of participation in the
screening program [29]. And ﬁnally, a study from the Danish
Lung Cancer Screening Trial revealed that participants having a
false-positive spiral CT scan result change their habits by
smoking less, which was interpreted as an indication of the
emotional impact of false-positive screening results [30]. A sub-
stantial limitation of the two ﬁrst studies is the use of generic
instruments to capture potentially adverse effects of lung cancer
screening. In the study from Pittsburgh, the State-Trait Anxiety
Inventory (STAI) was used to measure anxiety [31]. The STAI has
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previously been shown to be less sensitive than a breast cancer
screening speciﬁc instrument, the Psychological Consequences
Questionnaire (PCQ) [32,33]. The STAI has also demonstrated
inadequacy in relation to language and content validity in cancer
screening [10], and insufﬁcient psychometric properties [34]. The
Belgian-Dutch study used the 12-item Short Form (SF-12), the
EuroQol questionnaire (EQ-5D), the STAI-6, and the Impact of
Event Scale, which are all generic health-related quality-of-life
instruments or utility measures [29]. No test on content relevance
and content coverage of these instruments was reported in the
article, neither were the psychometric properties of the generic
instruments [29]. Nevertheless, the studies from Pittsburgh [28]
and Denmark [30] conﬁrm lack of content validity for the generic
questionnaires used in a context of lung cancer screening: items
adapted from the PCQ about the perceived risk of cancer and
fear of cancer, and items about smoking habits all capture sig-
niﬁcant differences between persons with normal and persons
with abnormal screening results. Because generic measures do
not adequately capture the psychosocial aspects of cancer screen-
ing, a valid comprehensive measure needs to be developed to
capture the potential psychosocial harm of lung cancer screening.
A condition-speciﬁc questionnaire, Consequence of Screening
in Breast Cancer (COS-BC), which measures the psychosocial
consequences of abnormal and false-positive screening mammog-
raphy, has been developed on the basis of a Danish version of the
PCQ [35]. In a qualitative study using focus-group interviews
with women who had previously had a false-positive screening
mammography, the PCQ was considerably changed and
extended, with new items forming the COS-BC [35]. The
COS-BC was subsequently statistically validated in two quanti-
tative studies using the Item Response Theory and the Classical
Test Theory [7,8]. The COS-BC consists of two parts: part I is
especially relevant for the critical period from abnormal screen-
ing until ﬁnal diagnosis, and part II is only relevant after the
person has been declared free from suspicion of cancer.
The Danish Lung Cancer Screening Trial was launched in
October 2005 and has been designed to investigate potential
beneﬁts and harms of the screening program, including psycho-
social consequences [26].
It has previously been shown that many Danes perceive all
cancers as one and the same disease with one and the same bad
prognosis [36]. Therefore, it could be anticipated that the core
items of the COS-BC (i.e., the COS-BC without the breast-
speciﬁc items hereafter referred to as COS) would also be rel-
evant for participants in lung cancer screening. Therefore, the
purpose of the present study was threefold:
1. to examine the content relevance and content coverage
of the core items of the COS in a setting of lung cancer
screening;
2. if lack of content coverage of the COS was revealed, to
generate themes and new items especially relevant for par-
ticipants in lung cancer screening and to test the items for
suitability;
3. if new items were generated, to test the extended version of
the COS for dimensionality using the Item Response Theory
Rasch model.
Materials and Methods
Data Collection: Content Relevance and Content
Coverage of the COS for Application in Lung Cancer
Screening
Interviewees were recruited in the prevalence round of the
Danish Lung Cancer Screening Trial [26] to test the relevance
and content coverage of the COS in a setting of abnormal and
false-positive lung cancer screening.
Participants who, during the ﬁrst 6 months of the prevalence
round, had had an abnormal screening indicating a noncalciﬁed
nodule between 5 mm and 15 mm, and who were recalled for
another scan after 3 months were invited to participate in ﬁve
group interviews. The ﬁrst two authors of this article participated
as moderators in the group interviews.
The group interviews lasted approximately 2 hours and con-
sisted of two parts. The ﬁrst part was an open-ended discussion
on the psychosocial consequences of abnormal and false-positive
lung cancer screening results. The conceptualization of “psycho-
social consequences” was based on the biopsychosocial model in
which people are not regarded as passive [37]. They are consid-
ered as able to both interact with, and inﬂuence, the environment
[38,39].
In the second part of the ﬁrst group interview, the participants
were asked to complete the COS and to comment on the rel-
evance of the items. Part I of the COS encompasses three single
items and four domains (including 23 items), in total 26 items
with each four response categories: “not at all,” “a bit,” “quite
a bit,” and “a lot.” Part II encompasses four domains, including
13 items with each ﬁve response categories: “much less,” “less,”
“the same as before,” “more,” and “much more” [35]. The COS
items are ordered thematically in Table 1. The participants of the
ﬁrst group interview only completed part I of the COS because,
at the time of the interview, they did not know that their abnor-
mal screening results were false positive. In the four subsequent
group interviews, the participants completed versions of both
parts of the questionnaire that included new items generated
after the preceding group interview. In the group interviews,
cognitive interviewing was also carried out item by item and
covered understandability, content relevance, and content cover-
age [40,41].
The response options were also reviewed for relevance and
ease of completion. In part I, the response options are ordered as
categorical variables on a continuum going from “Not at all” to
“A lot” (Fig. 1).
The response options in part II are also categorical variables
on a continuum, but as can be seen in Figure 2, they are not
ordered on one continuum but two. In six group interviews with
women who had false-positive results from screening mammog-
raphy, it was revealed that the women’s experiences in the critical
period from abnormal screening mammography until ﬁnal false-
positive diagnosis were entirely different from their experiences
after the ﬁnal diagnosis. In addition, it was argued that some
issues could only be raised after the women had been declared
“free from” suspicion of cancer. The participants classiﬁed the
issues exclusively relevant to the period after the ﬁnal diagnosis
as long-term psychosocial consequences of false-positive screen-
ing mammography [35]. The women also claimed that the con-
sequences of the ﬁnal diagnosis were not all positive. Compared
with the time before participation in screening, the women
argued that after the ﬁnal diagnosis, there were negative as well
as positive consequences [35].
The COS-BC part II was developed so that each item included
response options indicating “no change” as an anchor relative to
two other options of changes in opposing directions. It is well
known that people’s values and perceptions of life can change as
a result of trauma and existential crisis. These changes can be
interpreted by the individual as positive, negative, or a combina-
tion of both. This has been seen in a qualitative study of cancer
patients’ reactions one or more years after diagnosis [42].
Another study showed that women with a diagnosis of breast
cancer experienced both positive and negative consequences of
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their disease [43]. Their positive reactions could be seen as a kind
of backward rationality, irrationality, or ambivalence. These
well-known phenomena are, for example, described in the psy-
chological theory of cognitive dissonance.
Antonovsky also reported similar complex reactions in inter-
views with former Jewish victims of the Second World War who
had spent time in concentration camps. Antonovsky described a
concept of a “sense of coherence” as a salutogenic model of the
relationship between health and disease [44]. Surprisingly,
Antonovsky found that not all the victims had a low sense of
coherence as a consequence of their traumas. Some victims had a
high sense of coherence despite their stay in concentration camps
[44,45].
Antonovsky did not use the positive reactions or greater sense
of coherence as justiﬁcation for sending people to concentration
camps. In comparison, Gram et al. reported an overall positive
impact on life as a long-term consequence of false-positive
screening mammography. Nevertheless, the authors emphasized
that it would be unreasonable to put this impact on the positive
side of the balance sheet of breast cancer screening, “since ﬁrst
the fear, then the relief, are induced by the same screening” [46].
Therefore, part II of the COS requires a particular item-scoring
system. It is important not to score the changes so that they
neutralize each other: therefore, an assessment of a mean score of
the dimensions does not express the actual distribution of
changes. The Rasch model presupposes that changes occur in one
direction only. It follows that any change from “The same as
before” is to be regarded as a long-term psychosocial conse-
quence of a false-positive screening result. Therefore, the
responses to part II should be recoded “laterally reversed”: a
response to “Much less” or “Much more” becomes a response to
one variable of “much less/more change,” a response to “Less”
or “More” becomes a response to one variable of “less/more
change,” and ﬁnally, a response to “The same as before”
becomes a response to a variable of “no change.”
The test version of the questionnaire including the new items
was subsequently ﬁeld-tested [47,48]. The ﬁeld tests were carried
out as individual interviews with ﬁve of the participants from the
group interviews. The interviewees were asked if the test version
of the questionnaire was easy to complete and if the layout was
easy to comprehend.
The group interviews were audio recorded, and after each
interview, the recording was independently audited by the ﬁrst
two authors, who conducted thematic analyses to determine the
key consequences of abnormal and false-positive lung cancer
screening results. In the subsequent group interviews, the identi-
ﬁed themes were discussed in detail. Furthermore, the partici-
pants’ verbatim comments were used to deﬁne a construct,
specifying a range of intensity from, for example, “little” to
“severe” “self-blame.” The items belonging to the construct were
compared in pairs to avoid redundancy by ensuring that they
qualitatively did not have the same intensity. Finally, the results
of the analyses were compared and, if they did not correspond,
Table 1 Content of the COS
Themes or
single items
The items of the COS.The number indicates the order
of appearance in the questionnaire
Part I
Anxiety 2. Worried about my future
3. Scared
12. Upset
13. Restless
14. Nervous
23. Terriﬁed
Behavioral 4. Irritable
5. Quieter than normal
8. Hard to concentrate
10. Change in appetite
17. Withdrawn into myself
20. Difﬁculty dealing with work or other commitments
22. Difﬁculty doing things around the house
Sense of dejection 1. Worried
9. Time passed slowly
11. Sad
15. Uneasy
18. Unable to cope
19. Depressed
Sleep 6. Slept badly
16. Taken long time to fall asleep
21. Woken up far too early in the morning
24. Awake most of the night
Single items 7. Busy to take mind off things
51. Less interest in sex
52. Sick leave
Part II
Lung cancer 3. Anxiety about lung cancer
13. Not lung cancer
Relaxed/calm 4. Relaxed
9. Calm
Social relations 6. Family
7. Friends
8. Other people
Existential values 1. Broader aspects of life
2. Enjoyment of life
5. Thought about future
10. Well-being
11. Awareness of life
12. Value life
COS, Consequence of Screening.
 Not
at all 
A bit
a bit 
A lot 
I have been worried. 
Quite 
Figure 1 The layout of the items in part I of
Consequence of Screening plus the new items in
the new themes in part I.
After the examinations……: 
Much less Less The same as before More Much more 
Less…….. More…….
Figure 2 The layout of the items in part II
of Consequence of Screening plus the new
items in the new themes: “impulsivity” and
“empathy.”
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the relevant sequences from the audio-recording were re-audited
and discussed until consensus was reached.
Data Collection for Statistical Psychometric Analysis
Data were collected from the years 2006 and 2007 from the ﬁrst,
second, and third screening incidence rounds in the Danish Lung
Cancer Screening Trial [26].
Part I
Persons with abnormal, false-positive, and true-positive screen-
ing results. All those with an abnormal screening result were
eligible. These persons were asked to complete part I of the
questionnaire 1 week after receiving the abnormal screening
result. The same persons, later diagnosed either with a false-
positive screening result or with lung cancer (true-positive
result), were all asked to complete part I 1 month after the ﬁnal
diagnosis.
Persons with normal screening results. For each person with an
abnormal screening result who was asked to complete the ques-
tionnaire, another two persons with normal screening results
were asked to complete part I of the questionnaire 1 week after
receiving their screening results. The two persons with normal
screening results were selected based on the following criteria:
1. Persons receiving a normal screening result within 1 week of
the person receiving the abnormal screening result.
2. Persons having the same sex as the person with the abnor-
mal screening result.
3. Persons of the same age (+/-3 years) as the person with the
abnormal screening result.
Persons with normal screening results were also asked to
complete part I of the questionnaire 1 month after receiving their
screening results.
Part II
Persons with false-positive and true-positive screening results.
These persons were asked to complete part II of the questionnaire
at 1, 6, and 18 months after the ﬁnal diagnosis.
Persons with normal screening results. These participants were
recruited, as described above, and were asked to complete part II
of the questionnaire at 1, 6, and 18 months after receiving their
screening results.
All persons were sent the questionnaire in the post and were
asked to complete and return it in an enclosed stamped addressed
envelope. A reminder was posted to those who had not returned
the questionnaire within 2 weeks.
Statistical Analyses on Dimensionality
Item responses were analyzed by the conditional distribution of
items given total person scores to avoid assumptions on the
distribution of the latent trait being measured. The pair-wise
estimation procedure implemented in the software program
RUMM2020 (Version 4.0 for Windows, RUMM Laboratory Pty
Ltd., Perth, WA, Australia) was used to estimate the item param-
eters [49,50]. The analysis of the ﬁt of item responses to the
partial-credit Rasch model was based on analyses of residuals
comparing observed to expected item responses, both for sepa-
rate individuals and for different score groups. The overall ﬁt of
the model was assessed by the Wright–Panchapakesan c2 statistic
summarizing standardized residuals over score groups and items
[51]. Item ﬁt statistics summarizing standardized residuals in
different score groups were used to identify items that did not ﬁt
the partial-credit Rasch model.
An analysis on differential item functioning (DIF) related to
time of assessment was conducted to determine if the items
functioned consistently over time and if there was any local
response dependence between the points of assessment at 1 week
and 1, 6, and 18 months after diagnosis/screening. If no DIF was
identiﬁed in relation to the time of assessment, then it was found
valid to pool the data from the different administrations for the
analyses of dimensionality and DIF in relation to other covariates
[52,53]. The DIF relative to person covariates was checked by
analyses of variance examining the degree to which individual
residuals for speciﬁc items depended on the covariates [54]. The
absence of an evidence of interaction between the covariates and
the estimated trait parameters was taken as an evidence of DIF
being uniform [55]. If one or more items in a dimension pos-
sessed uniform DIF, then the items were split stepwise, beginning
with the item possessing the greatest magnitude of uniform DIF
[56]. Items possessing nonuniform DIF were deleted from the
dimension.
Reliability was assessed by Cronbach’s alpha deﬁning the
lower bound for the test–retest correlation of the raw scores
[57,58] and by the Person Separation Index (PSI) calculating the
lower bound for the test–retest correlation of the estimated
values of the latent trait being measured [59].
When one Rasch analysis is conducted on two or more items,
information about the potential psychometric properties of the
scale and the items is revealed. In one Rasch analysis, it is
possible to generate information about the scale’s overall ﬁt to
the model expressed as a P-value, the total-item chi-square, and
the degrees of freedom. Two estimates about the scale’s reliability
are computed: the Cronbach’s alpha and the PSI. The informa-
tion generated about the items includes the item’s ﬁt to the Rasch
model, the individual item’s chi-square, degrees of freedom, the
item’s ability to discriminate (including under-discrimination and
over-discrimination), the functionality of the item’s response cat-
egories (order of thresholds of the response categories), the item’s
location relative to the other items, and ﬁnally, DIF (uniform or
non-uniform). Furthermore, information about how the items
and the responders are targeted in relation to each other is
revealed, including how much “information” the items are cap-
turing from the responders. In addition, the “item information”
captured by one item can be compared with the “information”
that the remaining items are capturing separately.
Items that are “problematic” in relation to the revealed infor-
mation described above, e.g., items that present a misﬁt to the
partial-credit Rasch model (deﬁned as P < 0.05 after a correction
of the Benjamini–Hochberg procedure [60]), items possessing
DIF, disordered thresholds, etc., are categorized as “poor” items.
If a scale encompasses one or more “poor” items, then these
items will affect the evidence concerning the other items on the
scale. For example, if a “poor” item has a strong DIF in one
direction, then evidence will suggest that the DIF will operate in
the opposite direction for other items on the scale: the DIF will
level out for the remaining items on the scale. Therefore, an item
possessing real DIF can affect other items on the scale to show
DIF—a DIF that is artiﬁcial. Should an item possessing real DIF
be split, the ﬁt to the Rasch model should increase—and vice
versa if an item with artiﬁcial DIF was to be split.
The items included in each theme in the COS and the items
included in each new lung cancer screening-speciﬁc theme were
analyzed individually to test whether the items in a theme ﬁtted
the partial-credit Rasch model. Except for items possessing
604 Brodersen et al.
uniform DIF, “poor” items possessing the greatest magnitude of
psychometric “problems” were deleted from the theme stepwise,
and a Rasch analysis was conducted with the remaining items
composing the theme.
The item on sick leave (no. 52, Table 1) and the two other
single items (nos. 7 and 51, Table 1) were not included in the
Rasch analyses because these items did not belong to any of the
other dimensions.
The Cronbach’s alpha was calculated using the software SPSS
for Windows version 16.0 (SPSS, Chicago, IL). For Rasch analy-
ses, the software RUMM2020 was used [50]. The study was
approved by the Danish Data Protection Agency.
Results
Results from the Interviews
Altogether, nine women and seven men participated in ﬁve group
interviews. Five women were interviewed before they knew that
their abnormal screening results were false positive. Four of these
women participated again in the last group interview, which was
conducted 2 months after they had been told that their screening
results were false positive (Table 2).
Three women and two men participated in the ﬁeld test.
During the ﬁeld test, only minor linguistic changes were made in
part I, e.g., “more than usual” was added to the item “I have
been aware of my weight,” a phrase that was already included in
several other items. Another example was that the word
“other(s)” had to be highlighted in items 32, 34, and 46 (see
Table 3). No items were changed in part II.
The items in the COS were all found relevant by the partici-
pants. Five themes especially relevant for the critical period were
extracted from the interviews: “self-blame,” “focus on symp-
toms,” “stigmatization,” “introvert,” and “harm of smoking.”
All ﬁve themes were generated in the ﬁrst group interview. Two
themes especially relevant for the period after known diagnosis
were identiﬁed: “impulsivity” and “empathy.” In addition,
“regretful of still smoking” occupied the minds of those partici-
pants who were currently smokers. These three themes were
generated in the second group interview.
Altogether, 26 new items for part I were generated. The
subject matter for these items was generated in the ﬁrst group
interview and was accepted in the following group interviews. In
all, 16 new items for part II were generated, and the subject
matter for these items was generated in the second group inter-
view and was accepted in the three subsequent group interviews.
The themes and the generated items matching these themes are
listed in Table 3.
Results of the Data Collection for the Statistical
Psychometric Analysis
There was a sample of 195 persons eligible to complete part I of
the questionnaire. Of those asked to participate, 183 (93.8%)
agreed to complete the questionnaire 1 week after screening, and
173 (88.7%) agreed to complete the questionnaire 1 month after
screening.
There was a sample of 195 persons eligible to complete part
II of the questionnaire at 1 and 6 months after screening. Of
these, 173 (88.7%) agreed to complete the questionnaire at 1
month after screening, and 164 (84.1%) agreed to complete the
questionnaire at 6 months after screening. At the time of their
inclusion in the present study (March 25, 2009), 111 of the 195
persons had known their screening result for 18 months. Of
these, 91 (82.0%) completed part II of the questionnaire.
Table 2 Participants in the group interviews
Sex Women Women Men Men Women
Number 5 4 4 3 4
Mean age and range 57.2 (53–63) 58.4 (55–63) 62.5 (59–66) 62.5 (62–64) 59.2 (58–63)
Stage in relation to
the screening result
Critical period 3 to 4 months after
ﬁnal result
4 to 5 months after
ﬁnal result
2 months after
ﬁnal result
2 months after
ﬁnal result
Table 3 The new themes and the new items generated in the group
interviews
Themes
The content of the new items.The number
indicates the order of appearance in the questionnaire
Part I
Self-blame 35. Blamed oneself*
36. Felt guilty*
38. Disappointed in oneself*
48. Angry with oneself*
50. Been annoyed with oneself*
Focus on (airway)
symptoms
26. Aware of one’s weight
27. Aware of being short of breath
37. Considered going to the doctor
40. More colds than usual
42. More tired than usual
45. Been aware of one’s coughing
47. Felt ill
49. Been aware of coughing up mucous
Stigmatization 32. Been told off by other people*
34. A ﬁnger wagging from others*
43. Felt stigmatized*
46. Blamed by other people*
Introvert 29. Fear of lung cancer at the back of one’s mind
31. Insecure
33. Sorry for oneself
39. Thought one’s situation hopeless
41. Mood swings
44. Keeping things from those who are close to you
Harm of smoking 25. Thought of smoking as harmful
30. Sorry*
Anxiety† 28. Shocked
Part II
Impulsivity 14. energy
16. Lived life to the full
19. Being impulsive
21. Desire to venture into something new
22. Desire to venture into something risky
23. Done some things that overstepped one’s bounds
Empathy 15. Responsibility for one’s family
18. Understand other people’s problems
20. Ability to listen to other people’s problems
Relaxed/calm‡ 17. Relieved
24. Are you currently smoking? If yes, please complete the questions below:
Regretful still
smoking
25. Thought about quitting smoking
26. Feel guilty for smoking
27. Annoyed with oneself for smoking
28. Disappointed in oneself for smoking
29. Change in one’s attitude toward smoking
30. Having second thoughts about one’s smoking
*For having smoked for many years.
†New item possibly belonging to the “old” anxiety scale in COS.
‡New item possibly belonging to the “old” relaxed/calm scale in COS.
COS, Consequence of Screening.
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Results from the Rasch Analyses
No DIF was identiﬁed in relation to the time of assessment.
Therefore, the data from the different administrations were
pooled for the Rasch analyses on dimensionality and DIF in
relation to covariates other than time of assessment.
Part I
Dimensionality of part I of the core-questionnaire COS. In part
I, only the sleep dimension from the core-questionnaire COS did
not include all original items. Item no. 24, “awake most of the
night,” (Table 1) did not ﬁt the Rasch model, whereas the
remaining three sleep items ﬁtted the partial-credit Rasch model
(Table 4). All the other items from the COS ﬁtted their respective
three dimensions, forming subscales of anxiety, sense of dejec-
tion, and negative impact on behavior (Table 4). One of the new
items, “shocked,” which was generated in the interviews in the
present study, belonged to the anxiety scale.
Some items in the anxiety and dejection dimensions possessed
DIF in relation to sex and diagnosis. Splitting those items
increased the ﬁt to the Rasch model (Table 4).
Dimensionality of part I of the lung cancer screening-speciﬁc
items. All ﬁve items covering the theme “self-blame” ﬁtted the
partial-credit Rasch model (Table 4). Only two of the eight items,
covering the theme “focus on symptoms,” ﬁtted the Rasch
model. Because these two items, “aware of being short of breath”
and “been aware of one’s coughing,” both described symptoms
from the airway, the subscale was renamed to “focus on airway
symptoms” (Table 4). The four “stigmatization” items, four out
of the six “introvert” items, and the two “harm of smoking”
items ﬁtted the Rasch model (Table 4).
Of the 26 new items in part I, 25 items covered the ﬁve
themes: “self-blame,” “focus on symptoms,” “stigmatization,”
“introvert,” and “harm of smoking.” Eight of these 25 items
were identiﬁed to be “poor” or single items. The summary results
of the item ﬁt statistics, their location, and order in the dimen-
sions of part I are listed in Table 5.
Part II
Dimensionality of part II of the core-questionnaire COS plus the
new “impulsivity” and “empathy” themes. The response pattern
in the items of part II of the COS and the items covering the two
new themes “impulsivity” and “empathy” was skewed so that
0% to 12.1% responded to the two response categories “Much
less” and “Less” (Fig. 2). As described in the method section,
Rasch analyses were performed after transforming the data by
recoding the item responses as “laterally reversed.” However,
because the data were skewed, it was also decided to investigate
the ﬁt of responses to Rasch models in two additional ways
(Table 6).
In part II, the two items making up the “lung cancer” dimen-
sion did not ﬁt a partial-credit Rasch model in two of the three
data sets (Table 7). Despite the ﬁt in the data set recoded “later-
ally reversed,” the reliability was low: PSI = 0.38 and Cronbach’s
alpha = 0.47. Low values of the PSI and Cronbach’s alpha could
be caused by bad targeting between items and persons, however,
this was not the case for the “lung cancer” dimension in any of
the three recoded data sets. Therefore, these two items have to be
regarded as single items. The new item “relieved” did not ﬁt the
original “relax/calm” dimension in any of the three data sets and,
therefore, has to be regarded as a single or “poor” item (Table 7).
All six dimensions ﬁtted the partial-credit Rasch model in all
three data sets except for the “existential” dimension in the data
set recoded “the same as before” (Table 7).
The item “broader aspects of life” did not ﬁt the “existen-
tial values” dimension. There was a marginal misﬁt for these
three other items and their respective dimensions: “thought
about future” and “awareness of life” both belong to the “exis-
tential values” dimension, and the item “energy” belong to the
“impulsivity” dimension. To avoid spurious signiﬁcant results
because of multiple testing, the Benjamini–Hochberg procedure
[60] was used to adjust the P-values to control the false dis-
covery rate. After adjusting the P-values for the three above-
mentioned items, these results should be regarded as
insigniﬁcant (Table 8).
All the items’ thresholds were in order in all the Rasch analy-
ses on the three recoded data sets.
Table 4 Wright–Panchapakesan (WP) ﬁt statistics, Person Separation Index, and the Cronbach’s alpha of nine dimensions in part I of the Consequence
of Screening in Lung Cancer and the “still regretful smoking” dimension in part II
Dimensions (Number of items)
WP
chi-square
Degrees of
freedom P
Person
Separation
Index
Cronbach’s
alpha (time 1/2/3)
Anxiety (7)—before splitting items 57.87 34 0.007* 0.89 0.90 (0.87/92)
Anxiety (7)—split item 3 for sex and items 2, 14, and 28 for diagnosis† 66.21 55 0.143 0.89
Behavioral (7) 47.82 35 0.073 0.87 0.88 (0.79/0.92)
Sense of dejection (6)—before splitting item 33.91 30 0.284 0.91 0.88 (0.91/0.86)
Sense of dejection (6)—split item 1 for diagnosis (abnormal) and item 15 for sex† 43.31 40 0.332 0.91
Sleep (4) 47.47 16 0.000058* 0.85 0.86 (0.88/0.83)
Sleep (3)—minus item 24 “awake most of the night” 22.15 12 0.035832‡ 0.80 0.75 (0.64/0.85)
Self-blame (5) 31.63 20 0.047372‡ 0.97 0.91 (0.94/0.89)
Focus on airway symptoms (2) 10.08 7 0.184 0.71 0.67 (0.048/0.82)
Stigmatization (4) 30.65 20 0.060 0.89 0.78 (0.74/0.81)
Introvert (4) 25,72 16 0.058 0.82 0.86 (0.80/0.91)
Harm of smoking (2) 6.94 7 0.435 0.81 0.84 (0.78/0.92)
Still regretful smoking (6) 72.55 12 <0.0000005* 0.84 0.86 (0.86/0.85/0.86)
Still regretful smoking (5)—minus item 29 “change in one’s attitude toward smoking” 26.06 10 0.004* 0.85 0.87 (0.87/0.87/0.86)
Still regretful smoking (4)—minus items 29 and 5 “feel guilty for smoking” 9.40 4 0.052 0.84 0.86 (0.86/0.87/0.83)
*Misﬁt after a correction of Benjamini–Hochberg procedure [60].
†The patients with lung cancer were excluded from these analyses.
‡Adjusting the P-values in the table to control the false discovery rate and to avoid spurious signiﬁcant results due to multiple testing suggested that this result should be regarded as insigniﬁcant
[60].
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Dimensionality of the Six New Items in Part II Covering
the Theme “Regretful of Still Smoking”
Four of the six new items covering “regretful of still smoking”
for those participants who were currently smokers ﬁtted a
partial-credit Rasch model (Table 4). The two items, “feel guilty
for smoking” and “change in one’s attitude toward smoking,”
must be regarded as “poor” or single items. The remaining four
items in the dimension are listed in order of location in Table 9.
None of the items in part II possessed DIF in relation to sex,
age, and diagnosis.
Discussion
All four dimensions from part I of the core-questionnaire
COS—anxiety, sense of dejection, negative impact on behavior,
and sleep—were found qualitatively relevant and psychometri-
Table 5 Summary of result of item ﬁt statistics and ordering in the dimensions of part I of the COS-LC
Dimension
The items of part I of the COS-LC in location order in the dimensions.
The number indicates the order of appearance in the questionnaire Chi-square
Degrees of
freedom
Probability of
ﬁt to the
Rasch model
Item
location
Anxiety 2. Worried about my future (split for diagnosis: “abnormal” and “false positive”) 1.266 5 0.938 -2.064
14. Nervous (split for diagnosis: “abnormal”) 6.007 5 0.306 -1.130
3. Scared (split for sex: “female”) 7.728 5 0.172 -0.345
13. Restless 8.223 5 0.144 -0.195
28. Shocked (split for diagnosis: “abnormal” and “false positive”) 8.366 5 0.137 -0.030
3. Scared (split for sex: “male”) 8.873 5 0.114 0.166
14. Nervous (split for diagnosis: “normal” & “false-positive”) 14.447 5 0.013008* 0.189
28. Shocked (split for diagnoses: “normal”) 3.002 5 0.700 0.348
12. Upset 2.008 5 0.848 0.615
23. Terriﬁed 3.268 5 0.659 0.691
2. Worried about my future (split for diagnosis: “normal”) 3.025 5 0.696 1.754
Behavioral 22. Difﬁculty doing things around the house 11.960 5 0.035344* -0.239
20. Difﬁculty dealing with work or other commitments 5.684 5 0.338 -0.146
5. Quieter than normal 9.082 5 0.106 -0.145
8. Hard to concentrate 4.189 5 0.523 -0.038
17. Withdrawn into myself 3.595 5 0.609 0.132
10. Change in appetite 5.836 5 0.322 0.184
4. Irritable 7.475 5 0.188 0.252
Sense of dejection 1. Worried (split for diagnosis: “abnormal”) 5.175 5 0.395 -1.79
15. Uneasy (split for sex: “female”) 7.482 5 0.187 -0.621
1. Worried (split for diagnosis: “normal” and “false positive”) 7.776 5 0.169 -0.583
11. Sad 7.100 5 0.213 -0.21
19. Depressed 2.841 5 0.725 -0.151
9. Time passed slowly 5.430 5 0.366 0.386
18. Unable to cope 3.888 5 0.566 0.886
15. Uneasy (split for sex: “male”) 3.619 5 0.605 2.083
Sleep 21. Woken up far too early in the morning 4.426 3 0.219 -0.191
6. Slept badly 14.863 4 0.004996* -0.046
16. Taken long time to fall asleep 2.865 5 0.721 0.237
Self-blame 36. Felt guilty† 6.305 4 0.178 -0.557
35. Blamed oneself† 11.104 4 0.025424* -0.43
50. Been annoyed with oneself† 3.525 4 0.474 0.169
38. Disappointed in oneself† 2.846 4 0.584 0.228
48. Angry with oneself† 7.853 4 0.097 0.589
Focus on airway
symptoms
27. Aware of being short of breath 4.706 4 0.319 -0.073
45. Been aware of one’s coughing 5.371 3 0.147 0.073
Stigmatization 43. Felt stigmatized† 10.226 5 0.069 -0.195
32. Been told off by other people† 3.272 5 0.658 -0.117
34. A ﬁnger wagging from others† 10.328 5 0.066 0.105
46. Blamed by other people† 6.819 5 0.234 0.207
Introvert 31. Insecure 7.509 4 0.111 -0.48
41. Mood swings 4.678 4 0.322 0.008
39. Thought one’s situation hopeless 5.607 4 0.230 0.113
33. Sorry for oneself 7.928 4 0.094 0.36
Harm of smoking 25. Thought of smoking as harmful 2.648 4 0.618 -0.261
30. Sorry† 4.292 3 0.232 0.261
*Adjusting the P-values in the table to control the false discovery rate and to avoid spurious signiﬁcant results due to multiple testing suggested that this result should be regarded as insigniﬁcant
[60].
†For having smoked for many years.
COS-LC, Consequence of Screening in Lung Cancer.
Table 6 Three different ways to recode the item responses in part II to able to conduct Rasch analysis
Much less Less
The same
as before More
Much
more
Data set recoded as “missing” Missing Missing 0 1 2
Data set recoded as “the same as before” 0 0 0 1 2
Data set recoded as “laterally reversed” 2 1 0 1 2
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cally valid for persons having abnormal and false-positive ﬁnd-
ings in screening for lung cancer. This was also valid for three of
the four dimensions from part II—calm/relax, social network,
and existential values. One new item was generated for the
anxiety scale and, together with the other six anxiety items, ﬁtted
a Rasch model. The two items involving belief and anxiety about
lung cancer did not measure the same construct and must be
regarded as single items.
Five new dimensions for part I of the questionnaire speciﬁ-
cally relevant for participants in lung cancer screening were
developed and conﬁrmed in a partial-credit Rasch model to
measure different constructs—“self-blame,” “focus on airway
symptoms,” “stigmatization,” “introvert,” and “harm of
smoking.” Three new dimensions for part II were also developed
and ﬁtted a Rasch model—“impulsivity,” “empathy,” and
“regretful of still smoking.”
There is a trade-off between developing a single scale that
includes many items and developing several scales that have a
smaller number of items. In the present study, the overall aim was
to develop a psychosocial measure for those having abnormal and
false-positive lung cancer screening results. The conceptualization
of “psychosocial consequences”was based on the biopsychosocial
model, whose name in itself indicates something multidimen-
sional. Another aim of the study was to develop a measure with
high content validity, including all relevant themes for participants
with abnormal and false-positive lung cancer screening results.
Linguistically, it is difﬁcult to pose many different questions for all
themes; we have, for example, identiﬁed four different qualities
within the theme “sleeping problems.” Therefore, developing a
multidimensional measure in a health-care area inwhichmembers
of the target population are regarded as the experts of the content
of the measure may result in scales with few items. Scales with few
items tend to be less reliable than scales with many items. Never-
theless, if many of the scales with few items measure the same
general construct operating in the same direction, then the con-
struct validity might be higher for a multidimensional measure
than for a unidimensional measure. When developing and vali-
dating the COS-BC, conﬁrmatory factor analyses (CFA) revealed
that the scales included in part I and the scales included in part II
of the COS measured the same overall construct, respectively
[7,8]. In the future, such CFA could also be conducted with data
collected using the COS in Lung Cancer (COS-LC).
The ﬁeld testing was carried out as face-to-face interviews
with ﬁve participants from the group interviews. These inter-
viewees were selected because they had been “good informants”
in the group interviews. A limitation of the ﬁeld test could be a
degree of dependence in the interviewees’ responses because they
had completed parts of the COS-LC, or a version close to the
ﬁnal version of the COS-LC previously. Nevertheless, the
purpose of the ﬁeld test was only to test the “user-friendliness”
and not the relevance and irrelevance of the items. Therefore, we
do not think that this hypothetical response dependence has
caused any problems.
All the new themes and the subject matter of all the new items
were generated during the ﬁrst two group interviews. The new
themes and the new items were accepted in the subsequent group
interviews. These resulted in robust evidence of high data
saturation and, thus, evidence of high content validity of the
COS-LC.
Eight new items in part I and one new item in part II did not
ﬁt the dimensions for which they were developed. These items
could either be regarded as “poor” or single items. This depends
on the items’ responsiveness because they were all found relevant
in the group interviews. When the psychosocial impact of lung
cancer screening is to be estimated from the longitudinal data
collected from all four incidence screening rounds in the Danish
Lung Cancer Screening Trial [26], the new items’ responsiveness
could be compared with the responsiveness of the Rasch ﬁtting
dimensions. If any statistically signiﬁcant differences are found
between persons having normal and abnormal screening results
Table 7 The Wright–Panchapakesan (WP) chi-square ﬁt statistics, the Person Separation Index, and the Cronbach’s alpha of the six dimensions in
Consequence of Screening in Lung Cancer part II
Dimensions
(no. of items)
WP
chi-square
Degrees of
freedom P
Person Separation
Index
Cronbach’s alpha
(time 1/2/3)
Recoding—Data set recoded as “missing”
Lung cancer (2) 18.30 5 0.002589* 0.57 0.56 (0.53/0.54/0.63)
Relaxed/calm (3) 33.35 12 0.000854* 0.69 0. 75 (0.70/0.78/0.79)
Relaxed/calm (2) 6.71 5 0.243 0.68 0.75 (0.71/0.82/0.67)
Social relations (3) 7.63 10 0.665 0.86 0. 85 (0.81/0.90/0.87)
Existential values (6) 44.94 30 0.039087† 0.81 0.84 (0.82/0.82/0.89)
Impulsivity (6) 27.64 24 0.276 0.84 0.83 (0.85/0.77/0.87)
Empathy (3) 14.13 10 0.167 0.66 0.69 (0.71/0.56/0.82)
Recoding—Data set recoded as “the same as before”
Lung cancer (2) 19.73 5 0.001409* 0.60 0.56 (0.53/0.54/0.61)
Relaxed/calm (3) 37.35 12 0.000196* 0.70 0.73 (0.68/0.76/0.79)
Relaxed/calm (2) 7.19 4 0.126 0.69 0.75 (0.73/0.80/0.68)
Social relations (3) 7.89 9 0.546 0.87 0.84 (0.79/0.89/0.87)
Existential values (6) 77.34 30 0.000005* 0.80 0.82 (0.80/0.80/0.87)
Impulsivity (6) 36.00 24 0.055 0.82 0.85 (0.87/0.82/0.86)
Empathy (3) 10.61 6 0.101 0.66 0.68 (0.71/0.55/0.81)
Recoding—Data set recoded as “laterally reversed”
Lung cancer (2) 9.46 5 0.092 0.38 0.47 (0.43/0.45/0.56)
Relaxed/calm (3) 25.14 12 0.014184* 0.68 0.73 (0.66/0.76/0.81)
Relaxed/calm (2) 4.72 4 0.317 0.61 0.70 (0.66/0.75/0.70)
Social relations (3) 12.30 9 0.197 0.86 0.84 (0.81/0.86/0.87)
Existential values (6) 38.22 30 0.144 0.83 0.85 (0.84/0.83/0.90)
Impulsivity (6) 23.83 24 0.471 0.85 0.88 (0.88/0.88/0.90)
Empathy (3) 9.89 6 0.129 0.66 0.69 (0.71/0.56/0.84)
*Misﬁt after a correction of Benjamini–Hochberg procedure [60].
†Adjusting the P-values in the table to control the false discovery rate and to avoid spurious signiﬁcant results due to multiple testing suggested that this result should be regarded as insigniﬁcant
[60].
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in the dimensional sum scores, then the same or greater impact
also needs to be identiﬁed in the new items if these are not to be
regarded as “poor.” Therefore, decisions about which new items
to delete from the questionnaire and which items to keep as
single items must be made when the results of the psychosocial
consequences of lung cancer screening have been assessed.
Several items in part I of the questionnaire were identiﬁed as
possessing DIF. After splitting those items in relation to the
covariables possessing DIF, the ﬁt to the Rasch model increased
in all cases. These results conﬁrmed that the identiﬁed DIF was
real and was not caused by some other bias.
When developing and validating part I of the COS-BC, there
were still some questions to be answered [8]. Some of these
questions concerned the core-questionnaire COS. All the items in
the COS were found relevant for participants in lung cancer
screening. Therefore, the unanswered questions may not only be
relevant in a population of women participating in breast cancer
screening, but also for participants in lung cancer screening. The
unanswered questions were the following:
1. Do the four items covering sleep form one dimension?
Answer: No, one of the items, “awake most of the night,”
did not ﬁt a Rasch model and must be regarded as a single
item.
2. Will the item “felt sad” still have uniform DIF?
Answer: This item did not possess DIF among participants
in lung cancer screening.
3. Will some items still have thresholds that are not in order?
Answer: All items in part I had their thresholds in order.
As expected, the themes “risk of cancer,” “fear of cancer,”
and “smoking habits,” already described in the literature as
consequences of participating in lung cancer screening, were also
identiﬁed in this study. Two dimensions were developed to
measure the theme about smoking habits—“harm of smoking”
in part I and “regretful of still smoking” in part II. The two single
items included in part II (Table 1), “anxiety about lung cancer”
and “belief in not having lung cancer,” cover the aspects about
risk and fear of lung cancer, which were also found in the
Pittsburgh study [28].
The two new dimensions generated for part II (Table 3),
“impulsivity” and “empathy,” and the three dimensions from
part II of the core-questionnaire COS (Table 1) all showed the
profound changes in attitude toward life that may occur after a
person has been declared free from suspicion of cancer. These
dimensions are all proxy measurements for how much fear and
worry the persons having abnormal screening results experienced
during the critical period from the abnormal screening result to
the ﬁnal true- or false-positive result.
The response options in part II allow for replies in opposite
directions (Fig. 2). This corresponds with the ﬁndings in a survey
where patients with a diagnosis of, and treated for, cancer expe-
rienced positive as well as adverse consequences [43]. It also
corresponds with the results of the Rasch analyses of part II. All
seven dimensions ﬁtted the Rasch model in the data set that was
recoded as “laterally reversed.” Here, responses in any of the two
opposing directions were regarded as long-term psychosocial
consequences. The ﬁt to the two other data sets recoded as
“missing” or as “the same as before” was less convincing, con-
ﬁrming that long-term psychosocial consequences should not
only be regarded as changes in one direction. Furthermore, the
ordering of the items also changed for some of the items in two
of the dimensions, “existential values” and “impulsivity,” again
due to changes in the items’ response after the recoding. There-
fore, the recoding “missing” and “the same as before” should
only be used in dimensions where all the items’ response patterns
are skewed. Furthermore, if future data collected with part II are
not skewed, then only the recoding as “laterally reversed” can be
used for Rasch analysis.
Qualitative studies have shown that patients with a diagnosis
of lung cancer feel stigmatized and blame themselves for their
cancer disease if they still smoke [61]. The group interviews in
the present study revealed that these themes were also important
for persons with abnormal screening results that were later con-
ﬁrmed to be false positive. Furthermore, the Rasch analysis also
conﬁrmed that these themes were distinct dimensions that were
measurable.
The authors of the Belgian-Dutch study on HRQoL effects on
participation in lung cancer screening argue for the necessity of
using generic instruments. They claim to be able to equate and
calibrate against other adverse health outcomes and screening
programs. Furthermore, they claim to be able to balance the
positive and negative effects of screening against costs by using
generic measures [29]. Nevertheless, besides the problem of irrel-
evance described in the introduction of the present article, such
assessments demand invariant psychometric properties across
different populations and different screening programs. In the
present study, several items were identiﬁed as possessing DIF.
This would most likely also be the case with the items in the
generic measures. Before comparison can be done between dif-
ferent screening programs or with other health-related outcome
measures, data collected using generic measures must be merged
and tested for DIF. If DIF is identiﬁed, then it means that the
comparisons between the screening programs and the cost esti-
mations are all biased. Nevertheless, it is possible to overcome
these biases if adjustment of the mean scores of the dimensions’
sum scores is done [55].
Conclusion
In conclusion, the reliability and dimensionality of a condition-
speciﬁc measure with high content validity for persons with an
abnormal and false-positive lung cancer screening results have
been demonstrated. The new questionnaire, COS-LC, covers in
two parts the psychosocial experiences of lung cancer screening.
Table 9 Summary of result of item ﬁt statistics and ordering in the “regretful of still smoking” dimension in part II of the COS-LC
The items composing the “regretful of still smoking” dimension in part II
of the COS-LC.The items are listed in location order, and the number
indicates the order of appearance in the questionnaire Chi-square
Degrees of
freedom
Probability of ﬁt to
the Rasch model Item location
24. Are you currently smoking? If yes, please complete the questions below: Single item Single item Single item Single item
25. Thought about quitting smoking 2.51 1 0.113 -1.662
28. Disappointed in oneself for smoking 2.22 1 0.136 -0.423
27. Annoyed with oneself for smoking 1.38 1 0.240 0.846
30. Having second thoughts about one’s smoking 3.28 1 0.070 1.239
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Part I: “anxiety,” “behavior,” “dejection,” “sleep,” “self-
blame,” “focus on airway symptoms,” “stigmatization,” “intro-
vert,” and “harm of smoking.”
Part II: “calm/relax,” “social network,” “existential values,”
“impulsivity,” “empathy,” and “regretful of still smoking.”
In addition, the measure includes several “poor” or single
items where future studies on the actual psychosocial impact of
lung cancer screening must decide whether these items should be
regarded as single items or deleted from the COS-LC.
Perspectives
The COS-LC is currently in use in two surveys in Denmark [26]
and The Netherlands [25]. It is planned to translate and adapt
the COS-LC into British English and German to be used in
surveys in the UK and Germany, respectively. Future analyses on
data from these surveys will make it possible to analyze the
psychometric properties of each single language version of the
COS-LC and, also, to compare the psychosocial consequences of
lung cancer screening between the four countries. These analyses
will contribute to the ﬁnal construction of the COS-LC.
The items and the dimensions listed in Table 1 comprising the
core-questionnaire COS have been shown to be relevant and
valid in breast cancer screening and lung cancer screening. The
common core-questionnaire COS provides the opportunity for
Rasch analysis to be used to compare the psychosocial conse-
quences of the two screening programs. Nevertheless, future
Rasch analysis on DIF has to be conducted to explore the con-
sistency of the COS.
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